Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blink Device Company’s flagship product, TwitchView, is a commercially available, FDA 510(k)-cleared quantitative neuromuscular monitor. It uses EMG technology to provide objective measurement of neuromuscular blockade in surgical patients. The device is used by anesthesia providers to guide dosing of muscle relaxants and reversal agents, aiming to improve patient safety and outcomes by reducing residual paralysis after surgery. Clinical studies have demonstrated the importance of such quantitative monitoring for optimal recovery from neuromuscular blocking agents.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Blink Device Company.